Mullu Tessema

Mullu Tessema is an experienced scientific professional currently serving as a Principal Associate Scientist at Frontera Therapeutics since November 2021. Prior roles include Senior QC Analyst for Bio-Assay at Agenus from November 2019 to October 2021 and Analyst II in QC Biochemistry and Cell Biology at Takeda/Shire from September 2015 to October 2019. Mullu began the career as a QC Analyst at Shire HGT, where employment extended from June 2009 to September 2015. Mullu holds a Bachelor of Biomedical and Clinical Science degree from Boston University, awarded between 2008 and 2011.